DAT Test in Veterinary Diagnostics: Uses and Interpretation

The direct agglutination test (DAT) is a serological method that detects antibodies against infectious agents by mixing serial dilutions of serum with antigen-coated particles or whole organisms and observing visible clumping. In veterinary diagnostics, the DAT is used for detecting exposure to protozoan parasites such as Leishmania, Toxoplasma gondii, Neospora caninum, Encephalitozoon cuniculi, and Sarcocystis neurona, as well as for diagnosing immune-mediated hemolytic anemia (IMHA) in dogs and cats. This article explains the principles, procedures, interpretation, and clinical applications of the DAT for animal health professionals, students, and researchers.

The DAT is valued in field settings because it requires minimal laboratory infrastructure compared to immunofluorescence assays or enzyme-linked immunosorbent assays (ELISA). For visceral leishmaniasis, the DAT has become a preferred test for field studies because it is simple and requires no specialized laboratory facilities. Understanding how to perform, interpret, and troubleshoot the DAT helps veterinarians and researchers make accurate diagnostic decisions and avoid common interpretation errors.

At a Glance

What the Direct Agglutination Test Measures

The DAT detects antibodies that bind to antigens on the surface of whole organisms or coated particles, causing them to clump together. When serum containing specific antibodies is mixed with a suspension of antigen-coated particles, the antibodies cross-link adjacent particles and form visible aggregates. The highest serum dilution that still produces visible agglutination is reported as the titer.

For infectious disease diagnosis, the DAT typically uses whole organisms such as Leishmania promastigotes, Toxoplasma tachyzoites, or microsporidian spores as the antigen. The test detects IgG antibodies in most formats, although some versions detect other immunoglobulin classes. For example, a direct agglutination test developed for Encephalitozoon cuniculi detects IgG antibodies and uses eosin-stained spores incubated overnight with test sera in round-bottom microtiter plates. Positive samples produce an opaque mat spread across the well, while negative samples form a compact button at the bottom.

For IMHA diagnosis, the DAT detects antibodies or complement proteins attached to the surface of red blood cells. This application is distinct from infectious disease serology because it looks for autoantibodies instead of antibodies against pathogens. The traditional DAT for IMHA uses washed red blood cells mixed with anti-species globulin reagents to detect bound antibodies or complement.

Core Principles of Agglutination Testing

Agglutination tests rely on the interaction between antibodies and surface antigens. Several factors determine whether visible agglutination occurs.

Antigen Density and Accessibility

The number and arrangement of antigenic sites on the particle surface influence test sensitivity. Organisms with dense surface antigen expression produce stronger agglutination reactions. For Leishmania, the molecular basis of agglutination is not fully characterized, but experiments have provided clues about the antigens responsible for agglutination of promastigotes by patient serum. The test works reliably even though the specific antigen targets are not completely defined.

Antibody Class and Avidity

IgG antibodies are the primary target in most DAT formats for infectious disease. IgM antibodies can also cause agglutination and may be detected depending on the test protocol. The avidity, or overall binding strength, of the antibody population affects how firmly the agglutination mat forms. High-avidity antibodies produce stable mats, while low-avidity antibodies may produce weak or incomplete agglutination.

Serum Reducing Agents

Some DAT protocols include a reducing agent such as 2-mercaptoethanol to break disulfide bonds in IgM antibodies. This step reduces false-positive reactions caused by IgM antibodies that may cross-react with unrelated antigens. In freeze-dried direct agglutination tests for visceral leishmaniasis, 2-mercaptoethanol has been replaced by urea or sodium dodecyl sulfate as safer alternatives. Research comparing these replacements found that urea performed comparably to 2-mercaptoethanol in maintaining test reliability.

Incubation Conditions

Temperature and incubation time affect the rate and strength of agglutination. Most DAT protocols require overnight incubation at room temperature or 37°C. The E. cuniculi DAT described in the literature uses overnight incubation with eosin-stained spores in round-bottom microtiter plates. Consistent incubation conditions are essential for reproducible results.

DAT Procedure for Infectious Disease Serology

The standard DAT procedure follows a systematic workflow that can be adapted to different pathogens and sample types.

Step 1: Serum Preparation

Collect blood into plain tubes without anticoagulant for serum separation. Allow the blood to clot at room temperature, then centrifuge and collect the serum. Heat inactivation at 56°C for 30 minutes is used in some protocols to destroy complement and reduce nonspecific reactions. For the freeze-dried direct agglutination test for visceral leishmaniasis, the reference protocol specifies a maximum storage temperature of 35°C for the commercial product, which is lower than the 56°C initially established.

Step 2: Serum Dilution

Prepare serial two-fold dilutions of serum in buffer or saline. The starting dilution and dilution range depend on the test protocol and the expected antibody levels. For visceral leishmaniasis, a single sample dilution at the cutoff titer of 1:3,200 has been validated as an alternative to full titration, using significantly smaller antigen volumes. This approach reduces cost while maintaining diagnostic reliability.

Step 3: Antigen Addition

Add a standardized suspension of antigen to each well. The antigen concentration affects test performance. For the improved freeze-dried direct agglutination test for leishmaniasis, a promastigote concentration of 1.4 × 10⁷ per milliliter was validated, compared to 9.0 × 10⁷ per milliliter in non-expired reference batches. Lower antigen concentrations reduce cost without compromising reliability.

Step 4: Incubation

Cover the plates and incubate according to the protocol. Overnight incubation is common. The E. cuniculi DAT uses overnight incubation with eosin-stained spores. Some rapid formats have been developed for field use, such as the fast agglutination screening test for Leishmania infantum in dogs, which provides quicker results than the standard DAT.

Step 5: Reading and Recording

Read the plates against a white background. Positive reactions show an opaque mat spread across the well bottom. Negative reactions show a compact button or dot at the center of the well. Record the highest dilution with visible agglutination as the titer. For the E. cuniculi DAT, positive samples produce an opaque mat, while negative samples form a button.

Interpretation of DAT Titers

Titer interpretation requires knowledge of the specific test, the pathogen, the host species, and the epidemiological context. A single positive result indicates exposure to the pathogen but does not necessarily indicate active disease.

Seropositivity Cutoffs

Each DAT format has an established cutoff titer that distinguishes positive from negative samples. For the modified direct agglutination test for Toxoplasma gondii in cats, the cutoff for seropositivity is a titer of 40. In a study of 200 domestic cat samples from Estonia, 120 samples (60.0%) tested positive with the DAT and 114 (57.0%) tested positive with a commercial ELISA. The percent agreement between the two tests was 95.0% with a kappa value of 0.8971, indicating almost perfect agreement.

Titer Magnitude and Disease Status

Higher titers generally indicate more recent or more intense antigenic stimulation, but the relationship between titer and clinical disease varies by pathogen. For visceral leishmaniasis, the DAT is used to diagnose the severe clinical syndrome, and serology plays an important role in diagnosis. For Neospora caninum, the DAT reliably detects and quantifies IgG antibodies in both experimental and natural infections across various animal species when compared with the indirect fluorescent antibody test.

Cross-Reactivity Considerations

Cross-reactivity between related pathogens can complicate interpretation. For Encephalitozoon cuniculi, the DAT showed 86% sensitivity and 98% specificity, with limited cross-reactivity to Encephalitozoon intestinalis and no cross-reactivity to Encephalitozoon hellem. Cross-reactivity between other Encephalitozoon species is common with IFA and ELISA methods, which is one reason the DAT was developed for this pathogen.

Population-Level Interpretation

In herd or flock testing, the proportion of seropositive animals and the distribution of titers provide information about disease transmission. For Toxoplasma gondii in cats, seropositivity indicates previous exposure, and seropositive cats are presumed to have shed oocysts earlier and to be chronically infected. For poultry mycoplasmosis, serological examination by slide agglutination, hemagglutination inhibition, or ELISA is one component of diagnosis alongside isolation and identification of the organism.

DAT for Immune-Mediated Hemolytic Anemia

The DAT has a distinct application in small animal medicine for diagnosing immune-mediated hemolytic anemia in dogs and cats. This test detects antibodies or complement on the surface of red blood cells, providing evidence that the immune system is destroying the patient's own red blood cells.

Traditional DAT for IMHA

The traditional DAT for IMHA uses anti-species globulin reagents to detect IgG, IgM, or complement on red blood cells. A positive result supports a diagnosis of IMHA when combined with clinical signs and laboratory evidence of hemolysis. The test is performed on blood samples collected with anticoagulant to prevent clotting.

Gel-Based DAT

A gel-based DAT has been developed as an alternative to the traditional tube-based test. In a study comparing the two methods, canine and feline blood samples were submitted for DAT testing to two laboratories. The kappa values for agreement between the tests were 0.86 for canine and 0.58 for feline samples in one laboratory, and 0.48 for canine samples in the other laboratory. The lower agreement in the second laboratory was caused by a high number of positive canine DATs for which the gel test was negative. This group included significantly more dogs with secondary IMHA.

Clinical Interpretation of DAT Results in IMHA

A positive DAT confirms immune-mediated red blood cell destruction but does not distinguish between idiopathic and secondary IMHA. The gel-based test may be used as a screening test for idiopathic IMHA and is less often positive in secondary IMHA than the traditional DAT. Clinical context, including underlying diseases, drug exposure, and other laboratory findings, is essential for interpreting DAT results in anemic patients.

Applications in Specific Animal Diseases

The DAT has been validated for several important animal diseases. Understanding the evidence base for each application helps clinicians choose the appropriate test and interpret results correctly.

Visceral Leishmaniasis in Dogs

Canine leishmaniasis is a significant veterinary and public health concern. The disease has a cryptic nature, and parasites may be absent from lesions or lymph nodes, making direct detection difficult. Some diagnostic tools lack complete sensitivity, which has driven the development of improved serological tests.

The freeze-dried direct agglutination test has been validated for detecting leishmaniasis in the canine reservoir. An improved version uses citrate-saline formaldehyde as an anti-clumping agent for antigen reconstitution instead of normal saline, and a lower promastigote concentration of 1.4 × 10⁷ per milliliter compared to the original reference formulation. This improved version achieved a 150% reduction in test application cost. Expired test batches approximately four years old were successfully revitalized to full validity. A batch reconstituted with citrate-saline formaldehyde maintained stability for approximately 12 months, compared to a 48-hour shelf life for the original formulation.

The improved freeze-dried direct agglutination test showed highly concordant results with the indirect immunofluorescence antibody test and ELISA for routine canine leishmaniasis diagnostics. Both the liquid and freeze-dried versions of the DAT are practical and feasible diagnostic alternatives compared to methods that require specialized skills and equipment.

Toxoplasmosis in Cats and Other Species

Toxoplasmosis is caused by the zoonotic protozoan parasite Toxoplasma gondii. Domestic cats and other felids are the definitive hosts. Serology is widely used in epidemiological studies to estimate the proportion of domestic cats that have encountered the parasite.

The modified direct agglutination test is commercially available for feline samples. In a comparative study, the DAT and a commercial ELISA showed almost perfect agreement for screening naturally exposed domestic cats. The DAT cutoff for seropositivity was a titer of 40. The DAT has also been evaluated for detecting Toxoplasma gondii in wild animals, and a comparison of the indirect immunofluorescent antibody test and modified direct agglutination test has been conducted in adult sheep in Spain.

Neosporosis in Multiple Species

Neospora caninum causes abortion and neuromuscular disease in cattle and dogs. A direct agglutination test was evaluated for the detection and quantitation of IgG antibodies in both experimental and natural infections in various animal species. Compared with the indirect fluorescent antibody test, the DAT appeared reliable for serologic diagnosis of neosporosis in a variety of animal species. The test provides easily available and inexpensive tools for serologic testing in many host species.

Encephalitozoonosis in Rabbits and Other Species

Encephalitozoon cuniculi is a small protozoan parasite in the phylum Microspora that naturally infects several host species, including humans. Infection is usually asymptomatic except in young or immunocompromised hosts. The DAT developed for this pathogen detects IgG antibodies using eosin-stained spores in round-bottom microtiter plates. The test is 86% sensitive and 98% specific for E. cuniculi, with limited cross-reactivity to Encephalitozoon intestinalis and no cross-reactivity to Encephalitozoon hellem. The test is fast and easy to conduct, and species-specific antibodies are not required.

Sarcocystosis in Horses

Sarcocystis neurona causes equine protozoal myeloencephalitis, a serious neurological disease of horses. A direct agglutination test has been developed for the detection of antibodies to Sarcocystis neurona in experimentally infected animals. This test provides a tool for serological diagnosis and epidemiological studies of this important equine pathogen.

Trypanosomiasis in Horses

Trypanosoma evansi causes surra, a disease affecting horses and other livestock in tropical and subtropical regions. A direct agglutination test has been described for serological diagnosis of Trypanosoma evansi infection in horses. This application demonstrates the versatility of the DAT format across different protozoan pathogens.

Mycoplasmosis in Poultry

Mycoplasma infections in poultry are diagnosed by isolation and identification of the organism, serological examination, or molecular biology tests. Serological methods include slide agglutination, hemagglutination inhibition, and ELISA. While the DAT is not the primary serological test for poultry mycoplasmosis, the diagnostic approach for these infections illustrates the broader context of serological testing in production animals. The most important mycoplasmas in domestic avian species include Mycoplasma gallisepticum, M. synoviae, M. meleagridis, and M. iowae.

Practical Implementation and Assessment Steps

Implementing the DAT in a veterinary practice or research laboratory requires attention to quality control, standardization, and staff training.

Step 1: Select the Appropriate DAT Format

Choose the DAT format validated for the target pathogen and host species. Commercial kits are available for some applications, such as the Toxo-Screen DA for Toxoplasma gondii. For other pathogens, in-house tests may be the only option. Consider the test volume, available equipment, and staff expertise when selecting a format.

Step 2: Establish Standard Operating Procedures

Write detailed standard operating procedures that specify reagent preparation, serum dilution schemes, incubation conditions, and reading criteria. Include photographs or diagrams of positive and negative reaction patterns for staff reference. The procedure for reconstituting freeze-dried antigen is particularly important, as the diluent affects test performance.

Step 3: Validate the Test in Your Laboratory

If using an in-house DAT, validate the test against a reference method using known positive and negative samples. For the E. cuniculi DAT, validation in CD-1 and C3H/He mice infected with E. cuniculi or two other Encephalitozoon species established the sensitivity and specificity of the test. Document the validation results and establish quality control limits.

Step 4: Train Personnel

Ensure that all personnel who perform or read the DAT receive standardized training. Reading agglutination patterns requires practice, and inter-operator variability can affect results. Use a panel of known positive, weak positive, and negative samples for training and periodic competency assessment.

Step 5: Implement Quality Control

Include positive and negative control samples in every test run. Monitor control performance over time to detect reagent deterioration or procedural errors. For freeze-dried antigens, track the expiration date and storage conditions. The maximum storage temperature for the commercial reference visceral leishmaniasis freeze-dried direct agglutination test is 35°C, which is lower than the 56°C initially established.

Step 6: Maintain Records

Record the date, operator, reagent lot numbers, control results, and patient results for each test run. Maintain a log of reagent receipt, reconstitution dates, and storage conditions. These records support troubleshooting and quality assurance reviews.

Records and Measurements

Accurate record keeping is essential for interpreting DAT results and monitoring test performance over time.

Sample Information

Record the animal identification, species, breed, age, sex, and clinical history for each sample. Note the date of sample collection and the date of testing. For herd testing, record the group or pen identification and the sampling strategy.

Test Results

Record the titer for each sample as the highest dilution with visible agglutination. For samples tested at a single dilution, record the result as positive or negative at that dilution. Include the cutoff titer used for interpretation.

Quality Control Records

Document the results of positive and negative controls for each test run. Track control performance over time to identify trends that may indicate reagent deterioration. For the freeze-dried direct agglutination test, monitor the reconstitution date and the stability period. A batch reconstituted with citrate-saline formaldehyde maintained stability for approximately 12 months at 4°C.

Reagent Inventory

Maintain a log of reagent lot numbers, receipt dates, expiration dates, and reconstitution dates. For freeze-dried antigens, note the storage temperature and any deviations from recommended conditions. An expired batch approximately seven years old showed an approximately 50% loss in the number of promastigotes, but the promastigotes maintained similar morphology to a valid batch, implying that auto-agglutination instead of aging is the main reason for expiry.

Common Failure Patterns and Troubleshooting

Several recurring problems can affect DAT performance. Recognizing these patterns helps laboratories maintain test quality.

Auto-Agglutination of Antigen

Antigen preparations can clump spontaneously, producing false-positive results. For Leishmania freeze-dried direct agglutination tests, auto-agglutination is the main reason for expiry. The substitution of normal saline with citrate-saline formaldehyde as an anti-clumping and preservative agent restored validity comparable to the freeze-dried original or liquid version. If auto-agglutination is suspected, examine the antigen control well, which contains antigen without serum. Agglutination in this well indicates antigen auto-agglutination.

Prozone Effect

High antibody concentrations can inhibit agglutination, producing false-negative results at low dilutions. This prozone effect occurs when excess antibody prevents cross-linking of antigen particles. Testing serial dilutions helps identify prozone effects because higher dilutions may show agglutination when lower dilutions do not. If the prozone effect is suspected, extend the dilution series.

Cross-Reactivity

Antibodies against related pathogens can produce positive results. For Encephalitozoon cuniculi, limited cross-reactivity to Encephalitozoon intestinalis was observed, while no cross-reactivity to Encephalitozoon hellem was found. Cross-reactivity between other Encephalitozoon species is common with IFA and ELISA methods. Consider the range of pathogens that could produce cross-reactions when interpreting positive results.

Reagent Deterioration

Freeze-dried antigens have a limited shelf life, and reconstituted antigens have a much shorter stability period. The original freeze-dried direct agglutination test formulation had a 48-hour shelf life after reconstitution, while the improved formulation with citrate-saline formaldehyde maintained stability for approximately 12 months. Track reconstitution dates and discard reconstituted antigen after the validated stability period.

Inconsistent Incubation Conditions

Variations in incubation temperature or time can affect agglutination patterns. Standardize incubation conditions and monitor incubator temperatures. Overnight incubation is specified for the E. cuniculi DAT, and deviations from this protocol can affect results.

Reading Errors

Agglutination patterns can be difficult to read, especially for weak positive samples. Use a standardized reading protocol with a light box or white background. Compare test wells with positive and negative controls. If reading is uncertain, repeat the test or have a second operator read the plate independently.

Limitations of the DAT

The DAT has several limitations that affect its utility in veterinary diagnostics.

Inability to Distinguish Exposure from Disease

A positive DAT indicates that the animal has been exposed to the pathogen and mounted an antibody response. It does not prove that the animal has active disease. For Toxoplasma gondii in cats, seropositivity indicates previous exposure, and seropositive cats are presumed to have shed oocysts earlier and to be chronically infected. Clinical assessment and other diagnostic tests are needed to determine whether the infection is causing disease.

Variable Sensitivity and Specificity

The sensitivity and specificity of the DAT vary by pathogen and test format. For Encephalitozoon cuniculi, the DAT is 86% sensitive and 98% specific. For other pathogens, the performance characteristics may differ. Laboratories should use the published performance data for the specific test format and pathogen when interpreting results.

Cross-Reactivity Between Related Species

Cross-reactivity can produce false-positive results in animals infected with related pathogens. The extent of cross-reactivity varies by pathogen and test format. For Encephalitozoon cuniculi, limited cross-reactivity to E. intestinalis was observed, but no cross-reactivity to E. hellem was found.

Time to Results

Standard DAT protocols require overnight incubation, which delays results compared to rapid tests. Some rapid formats have been developed, such as the fast agglutination screening test for Leishmania infantum in dogs, but these may have different performance characteristics than the standard DAT.

Requirement for Paired Samples

For some applications, demonstrating a rising titer requires testing paired samples collected two to three weeks apart. A single positive result provides limited information about the timing or progression of infection. Paired sampling is particularly important for distinguishing recent from past infection.

Safety and Regulatory Context

Handling animal samples and performing the DAT requires attention to biosafety and regulatory requirements.

Biosafety Considerations

Animal blood and serum samples may contain zoonotic pathogens. Encephalitozoon cuniculi naturally infects several host species, including humans. Toxoplasma gondii is a zoonotic parasite, and cats are the definitive hosts. Handle all samples as potentially infectious and follow standard biosafety precautions, including gloves, laboratory coats, and hand washing.

Chemical Safety

Some DAT protocols use reducing agents such as 2-mercaptoethanol, which is toxic and has an unpleasant odor. Safer alternatives such as urea or sodium dodecyl sulfate have been validated for the freeze-dried direct agglutination test for visceral leishmaniasis. If 2-mercaptoethanol is used, handle it in a fume hood and follow institutional chemical safety guidelines.

Regulatory Requirements

Serological tests for certain pathogens may be subject to regulatory requirements, particularly for international trade or disease control programs. For poultry mycoplasmosis, diagnosis is based on isolation and identification of mycoplasmas or serological examination of host sera. Eradication of mycoplasma infection can be achieved through improvements in hygiene and management practices, therapeutic treatment of breeder layers or hatching eggs, and better monitoring procedures. Consult relevant veterinary authorities for jurisdiction-specific requirements.

Professional Escalation Criteria

Veterinarians should escalate diagnostic decisions to specialized laboratories or reference centers when:

• Test results are inconsistent with clinical findings
• Confirmation of a positive result is needed for regulatory purposes
• The pathogen is notifiable or has public health implications
• Cross-reactivity is suspected and species-specific confirmation is required
• The laboratory lacks the capacity to perform confirmatory testing

For suspected zoonotic infections, consult public health authorities as required by local regulations.

Frequently Asked Questions

What is the difference between a direct agglutination test and an indirect agglutination test?

A direct agglutination test uses whole organisms or antigen-coated particles that are agglutinated directly by antibodies in the test serum. An indirect agglutination test uses particles coated with antibodies or antigens that react with a secondary reagent to produce visible agglutination. The DAT for infectious disease serology detects antibodies that bind to surface antigens on whole organisms such as Leishmania promastigotes or Toxoplasma tachyzoites.

How is the DAT different from ELISA for detecting antibodies?

The DAT detects antibodies by their ability to cross-link antigen-coated particles and produce visible clumping. ELISA detects antibodies by enzyme-linked secondary antibodies that produce a color change. The DAT requires no specialized equipment and is suitable for field use, while ELISA requires plate readers and trained personnel. For Toxoplasma gondii in cats, the DAT and ELISA showed almost perfect agreement in a comparative study.

What does a positive DAT titer mean in a dog with suspected leishmaniasis?

A positive DAT titer indicates that the dog has antibodies against Leishmania and has been exposed to the parasite. The titer magnitude provides information about the strength of the antibody response. For visceral leishmaniasis, the DAT is used to diagnose the severe clinical syndrome, and serology plays an important role in diagnosis. Clinical signs, other laboratory findings, and risk factors should be considered when interpreting the result.

Can the DAT distinguish between current and past infection?

A single positive DAT result cannot distinguish between current and past infection. Seropositivity indicates previous exposure, and the animal may be chronically infected. For Toxoplasma gondii in cats, seropositive cats are presumed to have shed oocysts earlier and to be chronically infected. Paired samples collected two to three weeks apart can demonstrate rising titers that indicate recent or active infection.

What causes false-positive results in the DAT?

False-positive results can be caused by auto-agglutination of the antigen, cross-reactivity with antibodies against related pathogens, and nonspecific agglutination due to improper sample handling. For Encephalitozoon cuniculi, limited cross-reactivity to Encephalitozoon intestinalis was observed. Auto-agglutination is the main reason for expiry of freeze-dried Leishmania antigen, and the use of citrate-saline formaldehyde as an anti-clumping agent addresses this problem.

How should samples be collected and stored for DAT testing?

Collect blood into plain tubes without anticoagulant for serum separation. Allow the blood to clot, centrifuge, and collect the serum. Store serum refrigerated for short periods or frozen for longer storage. Avoid repeated freeze-thaw cycles, which can degrade antibodies. For the freeze-dried direct agglutination test for visceral leishmaniasis, the maximum storage temperature for the commercial product is 35°C.

Is the DAT suitable for testing wild animals?

The DAT has been used for serological testing in wild animals. A study evaluated the usefulness of the DAT, ELISA, and polymerase chain reaction for the detection of Toxoplasma gondii in wild animals. The DAT has also been evaluated for Neospora caninum in various animal species and for Sarcocystis neurona in experimentally infected animals. The simplicity of the DAT makes it suitable for field studies where laboratory facilities are limited.

When should the DAT be used instead of other serological tests?

The DAT is preferred when laboratory facilities are limited, when rapid results are needed in the field, or when species-specific antibodies are not available. For visceral leishmaniasis, the DAT has become the preferred test for field studies because it requires no laboratory facilities. For Encephalitozoon cuniculi, the DAT was developed because IFA and ELISA require specialized equipment and show cross-reactivity between species. The choice of test depends on the pathogen, the available resources, and the purpose of testing.

Related Articles

• Veterinary Research and Industry Careers: Pharmaceuticals, Biotech, and Diagnostics
• Veterinary Research and Industry Careers: Pharmaceuticals, Biotech, and Diagnostics
• Wild Animals in Urban Areas: Safety and Coexistence Tips
• The Mirror Test in Animals: How Self-Recognition Is Measured and Why It Matters
• Self-Awareness in Animals: What the Mirror Test Reveals About Animal Cognition

References and Further Reading

• Research Data Framework. National Institute of Standards and Technology.
• EQUATOR Network. EQUATOR Network.
• Experimental Design Assistant. NC3Rs.
• NCBI Literature Resources. National Center for Biotechnology Information.
• PubMed. National Library of Medicine.
• The direct agglutination test: a non-specific test specific for the diagnosis of visceral leishmaniasis?. Annals of tropical medicine and parasitology, 1997.
• Direct agglutination test for Encephalitozoon cuniculi.. Veterinary parasitology, 2006.
• Direct agglutination test for serologic diagnosis of Neospora caninum infection.. Parasitology research, 1998.
• Modifications in a Reference Freeze-Dried Direct Agglutination Test to Improve Visceral Leishmaniasis Detection.. The American journal of tropical medicine and hygiene, 2020.
• Mycoplasmoses in poultry.. Revue scientifique et technique (International Office of Epizootics), 1996.
• Validation of an improved reference freeze-dried direct agglutination test for detecting leishmaniasis in the canine reservoir.. Access microbiology, 2025.
• Comparison of a commercial modified direct agglutination test and a commercial enzyme-linked immunosorbent assay for screening for antibodies against Toxoplasma gondii in naturally exposed domestic cats.. Parasitology research, 2019.
• Good agreement of conventional and gel-based direct agglutination test in immune-mediated haemolytic anaemia.. Acta veterinaria Scandinavica, 2012.
• Real-time structuring of the clinical information section for dopamine transporter SPECT reporting with a small language model pipeline: development and external validation. 2026.
• Recurrent Mixed Autoimmune Hemolytic Anemia With Evans Syndrome and High-Risk Relapse Features: A Case Report.. 2026.
• Assessment of Addictive Behavior in Rats with Partial Knockout of the Dopamine Transporter Gene. 2026.
• Warm Autoimmune Hemolytic Anemia in an Elderly Patient With a History of Chronic Idiopathic Thrombocytopenic Purpura: A Case Report.. 2026.
• Autoimmune Hemolytic Anemia Following Intravenous Immunoglobulin in Kawasaki Disease.. 2026.
• Noninvasive Electrophysiological Biomarkers of Olfactory Responses Across Cognitive States in Alzheimer Dementia: Cross-Sectional Study.. 2026.
• The usefulness of direct agglutination test, enzyme-linked immunosorbent assay and polymerase chain reaction for the detection of Toxoplasma gondii in wild animals.. Veterinary parasitology, 2016.
• A prototype of the direct agglutination test kit (DAT-Canis) for the serological diagnosis of canine visceral leishmaniasis.. Veterinary parasitology, 2016.
• Preparation of a Latex Agglutination Test (LAT) as A Rapid Direct and Indirect Diagnostic Tool for Detecting Bovine Viral Diarrhea Virus (BVDV) in Cattle. Alexandria Journal of Veterinary Sciences, 2018.
• Direct agglutination test for the detection of antibodies to Sarcocystis neurona in experimentally infected animals.. Veterinary parasitology, 2001.
• Comparison of indirect immunofluorescent antibody test and modified direct agglutination test methods for detection of Toxoplasma gondii antibodies in adult sheep in Spain.. Veterinary parasitology, 1996.
• Serological diagnosis of Trypanosoma evansi (Steel, 1885) in horses using a direct agglutination test.. Veterinary parasitology, 1993.
• Rapid detection of Leishmania infantum infection in dogs: A comparative study using fast agglutination screening test (FAST) and direct agglutination test (DAT) in Iran. Parasitology Research, 2009.

This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.